<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Legalizing Psilocybin</title>
    <meta name="description" content="Comprehensive guide to understanding the policy models for legalizing psilocybin">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Source+Sans+Pro:wght@300;400;600;700&display=swap, " rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&display=swap" rel="stylesheet">
    
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --background: #ffffff;
            --foreground: #09090b;
            --card: #ffffff;
            --card-foreground: #09090b;
            --primary: #18181b;
            --primary-foreground: #fafafa;
            --secondary: #f1f5f9;
            --secondary-foreground: #18181b;
            --muted: #f1f5f9;
            --muted-foreground: #64748b;
            --accent: #f1f5f9;
            --accent-foreground: #18181b;
            --border: #e2e8f0;
            --radius: 0.5rem;
        }

        body {
            background-color: var(--background);
            color: var(--foreground);
            line-height: 1.5;
        }

        .container {
            max-width: 80rem;
            margin: 0 auto;
        }

        .header {
            width: 100%;
            padding: 2rem 1.5rem;
        }

        .main-title {
            font-family: 'Bebas Neue';
            font-size: 2.25rem;
            font-weight: 400;
            color: var(--foreground);
            margin-bottom: 1rem;
            animation: fadeIn 0.6s ease-out;
        }

        .subtitle {
            font-size: 1.125rem;
            color: var(--foreground);
            max-width: 48rem;
            line-height: 1.625;
            animation: fadeIn 0.6s ease-out;
        }

        .main-content {
            padding: 0 1.5rem 4rem;
        }

        .grid {
            display: grid;
            gap: 2rem;
            margin-bottom: 4rem;
        }

        .grid-2 {
            grid-template-columns: 1fr;
        }

        .grid-4 {
            grid-template-columns: 1fr;
        }

        .card {
            background-color: var(--card);
            border-radius: 1rem;
            padding: 1.5rem;
            box-shadow: 0 1px 3px 0 rgba(0, 0, 0, 0.1);
            border: 1px solid var(--border);
            transition: box-shadow 0.3s ease;
            animation: fadeIn 0.6s ease-out;
        }

        .card:hover {
            box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1);
        }

        .main-feature {
            padding: 3rem;
        }

        .feature-header {
            display: flex;
            align-items: flex-start;
            gap: 1rem;
            margin-bottom: 1.5rem;
        }

        .icon-wrapper {
            padding: 0.75rem;
            border-radius: 0.75rem;
            display: flex;
            align-items: center;
            justify-content: center;
        }

        .icon-primary {
            background-color: rgba(24, 24, 27, 0.1);
        }

        .icon-accent {
            background-color: rgba(241, 245, 249, 0.8);
        }

        .icon-red {
            background-color: rgba(254, 226, 226, 1);
        }

        .icon-blue {
            background-color: rgba(219, 234, 254, 1);
        }

        .icon-green {
            background-color: rgba(220, 252, 231, 1);
        }

        .icon-purple {
            background-color: rgba(243, 232, 255, 1);
        }

        .icon {
            width: 2rem;
            height: 2rem;
            stroke: currentColor;
            fill: none;
            stroke-width: 2;
        }

        .icon-primary-color {
            color: var(--primary);
        }

        .icon-accent-color {
            color: var(--accent-foreground);
        }

        .icon-red-color {
            color: #dc2626;
        }

        .icon-blue-color {
            color: #2563eb;
        }

        .icon-green-color {
            color: #16a34a;
        }

        .icon-purple-color {
            color: #9333ea;
        }

        .feature-title {
            font-size: 1.875rem;
            font-weight: 600;
            color: var(--foreground);
            margin-bottom: 0.75rem;
        }

        .card-title {
            font-size: 1.25rem;
            font-weight: 600;
            color: var(--foreground);
            margin-bottom: 0.75rem;
        }

        .small-card-title {
            font-weight: 600;
            color: var(--foreground);
            margin-bottom: 0.5rem;
        }

        .feature-description {
            color: var(--muted-foreground);
            line-height: 1.625;
            font-size: 1.125rem;
        }

        .card-description {
            color: var(--muted-foreground);
            font-size: 0.875rem;
            line-height: 1.5;
            margin-bottom: 1rem;
        }

        .small-card-description {
            color: var(--muted-foreground);
            font-size: 0.875rem;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 1rem;
            margin-top: 2rem;
        }

        .stat-card {
            background-color: rgba(241, 245, 249, 0.5);
            border-radius: 0.5rem;
            padding: 1rem;
        }

        .stat-title {
            font-weight: 600;
            color: var(--foreground);
            margin-bottom: 0.5rem;
        }

        .stat-value {
            font-size: 0.875rem;
            color: var(--muted-foreground);
        }

        .notice {
            font-size: 0.75rem;
            color: var(--muted-foreground);
            background-color: var(--muted);
            border-radius: 0.5rem;
            padding: 0.75rem;
        }

        .statistics-section {
            background: linear-gradient(to right, rgba(24, 24, 27, 0.05), rgba(241, 245, 249, 0.05));
            border-radius: 1rem;
            padding: 3rem;
            animation: fadeIn 0.6s ease-out;
        }

        .statistics-title {
            font-size: 1.875rem;
            font-weight: 600;
            color: var(--foreground);
            margin-bottom: 2rem;
            text-align: center;
        }

        .statistics-grid {
            display: grid;
            grid-template-columns: 1fr;
            gap: 2rem;
        }

        .statistic {
            text-align: center;
        }

        .statistic-number {
            font-size: 2.25rem;
            font-weight: 700;
            color: var(--primary);
            margin-bottom: 0.5rem;
        }

        .statistic-description {
            color: var(--muted-foreground);
        }

        .content-sections {
            margin-top: 4rem;
            display: grid;
            grid-template-columns: 1fr;
            gap: 3rem;
        }

        .content-section {
            animation: fadeIn 0.6s ease-out;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            color: var(--foreground);
            margin-bottom: 1.5rem;
        }

        .section-text {
            color: var(--muted-foreground);
            line-height: 1.625;
            margin-bottom: 1rem;
        }

        @keyframes fadeIn {
            from {
                opacity: 0;
                transform: translateY(20px);
            }
            to {
                opacity: 1;
                transform: translateY(0);
            }
        }

        /* Responsive Design */
        @media (min-width: 768px) {
            .header {
                padding: 2rem 3rem;
            }

            .main-content {
                padding: 0 3rem 4rem;
            }

            .grid-2 {
                grid-template-columns: 2fr 1fr;
            }

            .grid-4 {
                grid-template-columns: repeat(2, 1fr);
            }

            .content-sections {
                grid-template-columns: repeat(2, 1fr);
            }
        }

        @media (min-width: 1024px) {
            .main-title {
                font-size: 3.75rem;
            }

            .subtitle {
                font-size: 1.25rem;
            }

            .feature-title {
                font-size: 1.875rem;
            }

            .feature-description {
                font-size: 1.125rem;
            }

            .statistics-title {
                font-size: 1.875rem;
            }

            .statistic-number {
                font-size: 2.25rem;
            }

            .grid-4 {
                grid-template-columns: repeat(4, 1fr);
            }
        }
    </style>
</head>
<body>
    <header class="header">
        <div class="container">
            <h1 class="main-title">Legalizing Psilocybin</h1>
            <p class="subtitle">
                A comprehensive guide to understanding the policy models for legalizing psilocybin 
                and its role in modern mental health treatment.
            </p>
        </div>
    </header>

    <main class="main-content">
         <div class="container"> 
            <!-- Featured Grid -->
           <div class="grid grid-4">
                <!-- Main Feature -->
                <div class="card">
                    <div class="icon-wrapper icon-red">
                        <svg class="icon icon-red-color" viewBox="0 0 24 24">
                            <path d="M20.84 4.61a5.5 5.5 0 0 0-7.78 0L12 5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12 21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0 0-7.78z"/>
                        </svg>
                    </div>
                    <h3 class="small-card-title">Mental Health</h3>
                    <p class="small-card-description">
                        Potential treatment for depression, anxiety, and PTSD
                    </p>
                    </div>
               </div>

                <!-- Research Card -->
                <div class="card">
                    <div class="icon-wrapper icon-accent">
                        <svg class="icon icon-accent-color" viewBox="0 0 24 24">
                            <path d="M6 2 3 6v14a2 2 0 0 0 2 2h14a2 2 0 0 0 2-2V6l-3-4Z"/>
                            <line x1="3" y1="6" x2="21" y2="6"/>
                            <path d="M16 10a4 4 0 0 1-8 0"/>
                        </svg>
                    </div>
                    <h3 class="card-title">Clinical Research</h3>
                    <p class="card-description">
                        Recent studies show promising results for treating depression, PTSD, 
                        and end-of-life anxiety.
                    </p>
                    <div class="notice">
                        FDA designated psilocybin as "breakthrough therapy" for treatment-resistant depression
                    </div>
                </div>
            </div> 

            <!-- Secondary Grid -->
            <div class="grid grid-4">
                <div class="card">
                    <div class="icon-wrapper icon-red">
                        <svg class="icon icon-red-color" viewBox="0 0 24 24">
                            <path d="M20.84 4.61a5.5 5.5 0 0 0-7.78 0L12 5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12 21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0 0-7.78z"/>
                        </svg>
                    </div>
                    <h3 class="small-card-title">Mental Health</h3>
                    <p class="small-card-description">
                        Potential treatment for depression, anxiety, and PTSD
                    </p>
                </div>

                <div class="card">
                    <div class="icon-wrapper icon-blue">
                        <svg class="icon icon-blue-color" viewBox="0 0 24 24">
                            <path d="M16 21v-2a4 4 0 0 0-4-4H6a4 4 0 0 0-4 4v2"/>
                            <circle cx="9" cy="7" r="4"/>
                            <path d="m22 21-3-3"/>
                            <path d="M16 21v-2a4 4 0 0 0-3-3.87"/>
                            <path d="M19 4v7"/>
                            <path d="M21 6l-2 2"/>
                        </svg>
                    </div>
                    <h3 class="small-card-title">Therapy Sessions</h3>
                    <p class="small-card-description">
                        Used in controlled therapeutic environments with professional guidance
                    </p>
                </div>

                <div class="card">
                    <div class="icon-wrapper icon-green">
                        <svg class="icon icon-green-color" viewBox="0 0 24 24">
                            <path d="M4 19.5v-15A2.5 2.5 0 0 1 6.5 2H20v20H6.5a2.5 2.5 0 0 1 0-5H20"/>
                        </svg>
                    </div>
                    <h3 class="small-card-title">Education</h3>
                    <p class="small-card-description">
                        Ongoing research and education about safe, therapeutic use
                    </p>
                </div>

                <div class="card">
                    <div class="icon-wrapper icon-purple">
                        <svg class="icon icon-purple-color" viewBox="0 0 24 24">
                            <path d="M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10"/>
                        </svg>
                    </div>
                    <h3 class="small-card-title">Safety</h3>
                    <p class="small-card-description">
                        Rigorous clinical protocols ensure patient safety and efficacy
                    </p>
                </div>
            </div>

            <!-- Content Sections -->
            <div class="content-sections">
                <div class="content-section">
                    <h2 class="section-title">Mechanism of Action</h2>
                    <p class="section-text">
                        Psilocybin works by binding to serotonin 5-HT2A receptors in the brain, 
                        particularly in areas responsible for mood, perception, and cognition. 
                        This interaction leads to increased neural connectivity and plasticity.
                    </p>
                    <p class="section-text">
                        The compound appears to temporarily reduce activity in the brain's 
                        "default mode network," which may explain its therapeutic effects on 
                        depression and anxiety disorders.
                    </p>
                </div> 

                <div class="content-section">
                    <h2 class="section-title">Current Legal Status</h2>
                    <p class="section-text">
                        While psilocybin remains federally illegal in the United States, 
                        several jurisdictions have decriminalized or are developing frameworks 
                        for therapeutic use under medical supervision.
                    </p>
                    <p class="section-text">
                        The FDA has granted "breakthrough therapy" designation for psilocybin-assisted 
                        therapy, expediting research and potential approval for specific medical conditions.
                    </p>
                </div>
            </div>
        </div>
    </main>
</body>
</html>



